Indian Journal of Urology
SYMPOSIUM
Year
: 2007  |  Volume : 23  |  Issue : 1  |  Page : 51--54

Use of bisphosphonates in prostate cancer: Current status


Rishi Nayyar, Narmada P Gupta 
 Department of Urology, All India Institute of Medical Sciences, New Delhi - 110 029, India

Correspondence Address:
Rishi Nayyar
C-61, New Multan Nagar, Rohtak Road, New Delhi
India

Bisphosphonates are a relatively newer class of drugs which have been used for the prevention of skeletal related complications of age related osteoporosis or metastatic disease from carcinoma breast or multiple myeloma. Their role in the management of prostate cancer is still under evolution. We hereby review the ongoing and some published randomized trials to define the role of bisphosphonates in various stages of prostate cancer.


How to cite this article:
Nayyar R, Gupta NP. Use of bisphosphonates in prostate cancer: Current status.Indian J Urol 2007;23:51-54


How to cite this URL:
Nayyar R, Gupta NP. Use of bisphosphonates in prostate cancer: Current status. Indian J Urol [serial online] 2007 [cited 2020 Jul 9 ];23:51-54
Available from: http://www.indianjurol.com/article.asp?issn=0970-1591;year=2007;volume=23;issue=1;spage=51;epage=54;aulast=Nayyar;type=0